Horizon Kinetics Asset Management’s AstraZeneca AZN Stock Holding History

Horizon Kinetics Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$951K	Sell	5,015 -241	-5%	-$45.3K	0.01%	164
2026 Q1	$1.04M	Sell	5,256 -241	-4%	-$46.5K	0.01%	166
2025 Q4	$1.01M	Sell	5,497 -241	-4%	-$42.3K	0.01%	165
2025 Q3	$880K	Sell	5,738 -238	-4%	-$36K	0.01%	183
2025 Q2	$835K	Sell	5,976 -452	-7%	-$63.3K	0.01%	199
2025 Q1	$945K	Sell	6,428 -10	-0.2%	-$1.45K	0.01%	182
2024 Q4	$844K	Buy	6,438 +261	+4%	+$36.5K	0.01%	195
2024 Q3	$963K	Sell	6,177 -308	-5%	-$49.7K	0.01%	183
2024 Q2	$1.01M	Sell	6,485 -218	-3%	-$32.8K	0.02%	161
2024 Q1	$908K	Buy	6,703 +1	+0%	+$132	0.02%	170
2023 Q4	$903K	Sell	6,702 -287	-4%	-$37.3K	0.02%	166
2023 Q3	$947K	Sell	6,989 -40	-0.6%	-$5.46K	0.02%	163
2023 Q2	$1.01M	Hold	7,029	–	–	0.02%	157
2023 Q1	$976K	Hold	7,029	–	–	0.02%	158
2022 Q4	$953K	Sell	7,029 -517	-7%	-$64.8K	0.02%	156
2022 Q3	$828K	Buy	7,546 +17	+0.2%	+$2.16K	0.02%	164
2022 Q2	$995K	Sell	7,529 -103	-1%	-$13.5K	0.02%	161
2022 Q1	$1.01M	Hold	7,632	–	–	0.02%	175
2021 Q4	$889K	Hold	7,632	–	–	0.02%	191
2021 Q3	$917K	Hold	7,632	–	–	0.02%	184
2021 Q2	$914K	Sell	7,632 -2,000	-21%	-$219K	0.02%	189
2021 Q1	$958K	Hold	9,632	–	–	0.02%	184
2020 Q4	$963K	Sell	9,632 -1,000	-9%	-$106K	0.03%	182
2020 Q3	$1.17M	Hold	10,632	–	–	0.05%	148
2020 Q2	$1.13M	Hold	10,632	–	–	0.04%	152
2020 Q1	$950K	Sell	10,632 -2,000	-16%	-$188K	0.04%	144
2019 Q4	$1.26M	Hold	12,632	–	–	0.04%	147
2019 Q3	$1.13M	Hold	12,632	–	–	0.03%	152
2019 Q2	$1.04M	Hold	12,632	–	–	0.03%	169
2019 Q1	$1.02M	Buy	+12,632	New	+$996K	0.03%	169

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Horizon Kinetics Asset Management's AZN Position: Q2 2026 in Review

Horizon Kinetics Asset Management reduced its AstraZeneca (AZN) stake by 4.6% in Q2 2026, selling an estimated $45.3K and leaving 5,015 shares worth $951K. The position accounts for 0.01% of the portfolio, ranked #164.

Horizon Kinetics Asset Management first reported a position in AZN in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.26M in Q4 2019. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Horizon Kinetics Asset Management held 5,015 shares of AstraZeneca worth $951K as of Q2 2026.
Horizon Kinetics Asset Management sold 241 AstraZeneca shares in Q2 2026, an estimated $45.3K.
AstraZeneca made up 0.01% of Horizon Kinetics Asset Management's portfolio in Q2 2026, its #164 holding.
Horizon Kinetics Asset Management first reported a position in AstraZeneca in Q1 2019 and has held it in 30 quarters since.
Horizon Kinetics Asset Management's AstraZeneca position peaked at $1.26M in Q4 2019.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Horizon Kinetics Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.